0
Skip to Content
NMD Pharma
Home
About
About NMD Pharma
Management team
Our team
Board
Founders
R&D
Pipeline
Science
Neuromuscular diseases
Insights
Scientific publications
News
Press releases
Events
Other news
Investors
Careers
Your career
Find your job
Contact
NMD Pharma
Home
About
About NMD Pharma
Management team
Our team
Board
Founders
R&D
Pipeline
Science
Neuromuscular diseases
Insights
Scientific publications
News
Press releases
Events
Other news
Investors
Careers
Your career
Find your job
Contact
Home
Folder: About
Back
About NMD Pharma
Management team
Our team
Board
Founders
Folder: R&D
Back
Pipeline
Science
Neuromuscular diseases
Insights
Scientific publications
Folder: News
Back
Press releases
Events
Other news
Investors
Folder: Careers
Back
Your career
Find your job
Contact
NMD Pharma appoints Dr. Jorge A. Quiroz as EVP, Chief Medical Officer
Press release Stine Krag Brunvold 5/10/22 Press release Stine Krag Brunvold 5/10/22

NMD Pharma appoints Dr. Jorge A. Quiroz as EVP, Chief Medical Officer

Read More
NMD Pharma expands its US presence
Press release Stine Krag Brunvold 5/3/22 Press release Stine Krag Brunvold 5/3/22

NMD Pharma expands its US presence

Read More
NMD Pharma Raises €35 Million in a new Financing
Press release Stine Krag Brunvold 2/15/22 Press release Stine Krag Brunvold 2/15/22

NMD Pharma Raises €35 Million in a new Financing

Read More
NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease
Press release Stine Krag Brunvold 7/8/21 Press release Stine Krag Brunvold 7/8/21

NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease

Read More
NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670
Press release Stine Krag Brunvold 6/30/21 Press release Stine Krag Brunvold 6/30/21

NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670

Read More
NMD Pharma Initiates an Observational Pilot Study Investigating the Effects of Sarcopenia on Neuromuscular Transmission in Older Adults
Press release Stine Krag Brunvold 6/1/21 Press release Stine Krag Brunvold 6/1/21

NMD Pharma Initiates an Observational Pilot Study Investigating the Effects of Sarcopenia on Neuromuscular Transmission in Older Adults

Read More
NMD Pharma Moves Corporate Headquarters to INCUBA to Support Future Growth
Press release Stine Krag Brunvold 11/30/20 Press release Stine Krag Brunvold 11/30/20

NMD Pharma Moves Corporate Headquarters to INCUBA to Support Future Growth

It all begins with an idea.

Read More
NMD Pharma Receives Grant from The Innovation Fund Denmark</a>
Press release Stine Krag Brunvold 11/30/20 Press release Stine Krag Brunvold 11/30/20

NMD Pharma Receives Grant from The Innovation Fund Denmark

It all begins with an idea.

Read More
NMD Pharma Initiates Combined Phase I/II Clinical trial
Press release Stine Krag Brunvold 10/6/20 Press release Stine Krag Brunvold 10/6/20

NMD Pharma Initiates Combined Phase I/II Clinical trial

It all begins with an idea.

Read More
NMD Pharma begins first clinical trial
Press release Stine Krag Brunvold 7/15/20 Press release Stine Krag Brunvold 7/15/20

NMD Pharma begins first clinical trial

It all begins with an idea.

Read More
NMD Pharma raises €38M (USD 47 Million) SERIES A</a> Financing
Press release Stine Krag Brunvold 3/23/18 Press release Stine Krag Brunvold 3/23/18

NMD Pharma raises €38M (USD 47 Million) SERIES A Financing

It all begins with an idea.

Read More
Newer Posts

NMD PHARMA A/S, CVR No. 36899069

Cookie Policy Terms of Use Privacy Policy US Expanded Access Policy

Follow us
LinkedIn and X